*Helicobacter pylori* (HP) infection has been reported to be hyperendemic in Saudi Arabia.\[[@CIT1]--[@CIT5]\] Reports in the 1990s have shown a prevalence of 68 -- 82.2%\[[@CIT1]--[@CIT5]\] in various age groups of patients including those with non-ulcer dyspepsia. This high prevalence has been attributed to several factors including sanitation and socioeconomic status.

Reports in the 2000s have shown marked reduction in the prevalence to 35 -- 55%.\[[@CIT6]--[@CIT8]\]

In Saudi Arabia, neither the prevalence of (HP) nor the clinical implication of such infection has been looked at in morbidly obese patients undergoing bariatric surgery. Few studies worldwide have shown a high prevalence of HP in morbidly obese patients undergoing bariatric surgery.\[[@CIT9]--[@CIT14]\]

Our aim in this study was to find out the prevalence of *Helicobacter pylori* infection in a group of morbidly obese Saudi patients referred for elective esophagogastroduodenoscopy (EGD) prior to bariatric surgery.

MATERIALS AND METHODS {#sec1-1}
=====================

We reviewed the medical records of the patients who were referred for EGD from June 2006 to Sep 2008 before bariatric surgery. Patients were included regardless of the type of surgery they underwent including gastric bypass, biliopancreatic diversion or vertical banded gastroplasty. The main indication for endoscopy was preoperative evaluation. Almost all patients were asymptomatic. Data recorded were patient demographics, co-morbid conditions, medication taken endoscopic and histological findings. All patients had three endoscopic gastric biopsy specimens for the identification of the HP infection, two from antrum and one from the body.

The presence or absence of HP was based on the histological identification of the organism by routine hematoxylin and eosin stain or special methylene blue stains.

RESULTS {#sec1-2}
=======

Sixty two patients were referred for upper GI endoscopy as pre bariatric surgery evaluation. Only six patients had mild dyspepsia. The mean age was 34 years (range 18 -- 51) and a mean BMI was 55 kg/m^2^ (range 35 - 92). The majority were females: 42 versus 20 males [Table 1](#T0001){ref-type="table"}. *Helicobacter pylori* infection was detected histologically in 53 patients (85.5%). All patients with positive HP organism in their biopsy specimens had chronic active gastritis of variable severe mild, moderate, or severe. Five patients had normal histological findings \[[Figure 1](#F0001){ref-type="fig"}\]. Four patients had quiescent gastritis without evidence of HP organisms. Three patients had intestinal metaplasia in association with HP organisms. *Helicobacter pylori* infection was present in 84% and 83% in patients with and without comorbid conditions, respectively. The main endoscopic findings were gastritis in 42 (67.7%), hiatus hernia in 8 (13%), and gastric erosions in 8 patients (13%) \[[Figure 2](#F0002){ref-type="fig"}\]. No endoscopic evidence of gastric or duodenal ulcer was found.

###### 

Demographic data and co-morbid conditions in 62 patients who underwent bariatric surgery

  --------------------------------------------------------------- -----------------
  Sex \[male/female\]                                             20/42
  Age \[years\][\*](#T000F1){ref-type="table-fn"}                 34 (18 -- 51)
  Weight \[Kg\][\*](#T000F1){ref-type="table-fn"}                 145 (69 -- 280)
  Body mass index \[kg/m^2^\][\*](#T000F1){ref-type="table-fn"}   55 (35 -- 92)
  Diabetes mellitus                                               28
  Hypertension                                                    22
  Bronchial asthma                                                6
  Hypothyroidism                                                  3
  Obstructive sleep apnea                                         3
  --------------------------------------------------------------- -----------------

Mean (range)

![Histological findings in 62 patients](SJG-16-264-g001){#F0001}

![Endoscopic findings in 62 patients highlight this portion](SJG-16-264-g002){#F0002}

DISCUSSION {#sec1-3}
==========

A high prevalence of HP infection in Saudi Arabia has been shown in various earlier studies.\[[@CIT1]--[@CIT5]\] A trend toward increasing prevalence with advancing age has also been shown\[[@CIT2][@CIT3][@CIT5][@CIT7]\] and a higher prevalence of 93% was reported in patients with duodenal ulcers.\[[@CIT3]\]

Significant reduction in infection rate has been demonstrated in recent reports\[[@CIT6]--[@CIT8]\] and a reduction of prevalence down to 63% has been reported in the population with duodenal ulcers.\[[@CIT15]\]

A prevalence rate as low as 35% has been reported in a random sample of medical students.\[[@CIT6]\]

No information in the literature is available to show the prevalence of HP infection in patients undergoing bariatric surgery from this country or nearby countries.

This study has shown an exceptionally high prevalence of the infection in unselected group of morbidly obese patients in a relatively young age group who have undergone EGD before weight reduction surgeries.

The explanation of such a high prevalence is not clear and has not been clarified.

It could probably be related to the study design since it was a retrospective analysis, although this effect would have been offset by a representative sample where the patients inclusion was random.

The basis of referring the patients for EGD was preoperative screening which was thought to be necessary by some surgeons and not by others. The difference in surgeons' views was the reason for referring some patients for screening EGD while not for the others.

Several reports from the west have shown a prevalence of 11 -- 39% in the morbidly obese group who underwent bariatric surgery; and the rates were higher than similar non-obese groups \[[Table 2](#T0002){ref-type="table"}\].\[[@CIT9]--[@CIT13]\] One recent study from USA has found a higher prevalence rate of 61% in morbidly obese compared to 48% in the control group, but this study looked only at the *H. pylori* serologies, which might not reflect a true active infection \[[Table 2](#T0002){ref-type="table"}\].\[[@CIT14]\]

###### 

Studies on the prevalence of HP in morbidly obese patients who underwent bariatric surgery

  Authors, year/type of study                          No. of patients   HP prevalence (%)   Control   HP (%)
  ---------------------------------------------------- ----------------- ------------------- --------- --------
  Renshaw *et al*.\[[@CIT9]\] 2001/ Retrospective      56                38                  500       21
  Papasavas *et al*.\[[@CIT11]\] 2008/ Retrospective   259               22.4                          
  Vanek *et al*.\[[@CIT12]\] 2006/ Retrospective       96                11                            
  De moura *et al*.\[[@CIT13]\] 2008/ Prospective      96                37.5                          
  Erim *et al*.\[[@CIT14]\] 2008/ Prospective          240               61                            48
  Azaqury *et al*.\[[@CIT16]\] 2006/ Retrospective     319               39                            
  Schermier *et al*\[[@CIT18]\] 2002/ Prospective      206               30                            
  Current study retrospective                          62                85.5                          

HP: *Helicobacter pylori*

Certain implications of the HP infection in bariatric surgery patients have been shown by few studies. These clinical implications include postoperative foregut symptoms, postoperative marginal ulcers, amount of weight loss, and delay of surgery.\[[@CIT10][@CIT16]--[@CIT18]\] In order to avoid these problems, eradication of *H. pylori* has been warranted after confirming the diagnosis.

Intestinal metaplasia is considered a premalignant condition, which is related to *Helicobacter pylori* infection. Around 5% of our patients had intestinal metaplasia. It necessitates treatment with eradication therapy, followed by endoscopic and histological examinations. The metaplasia in our group is lower than reported previously\[[@CIT19]\] but has clinical importance from the management point of view.

Unlike previous reports, this study has not shown a difference in rate of HP infection between patients with and without comorbid conditions.\[[@CIT20]--[@CIT22]\]

It might be necessary to screen these patients for the HP infection and give eradication treatment before subjecting them for surgeries.

We may need to follow our patients and expand the study prospectively and assess the prevalence of the infection in larger group of patients and observe the consequences postoperatively and examine the benefit of eradication treatment.

The study, nevertheless, has some limitations. It represents a retrospective chart review with a small sample size. However, it is the only preliminary report from Saudi Arabia and the results could reflect the persistence of the high prevalence of HP in a relatively young age group which probably could indicate hyperendemicty of the infection in Saudi Arabia.

CONCLUSIONS {#sec1-4}
===========

The study demonstrated a very high prevalence of *Helicobacter pylori* infection in morbidly obese Saudi patients who underwent bariatric surgery.

We may need to do more prospective studies to examine the implication of the infection and importance of HP eradication in this group of patients.
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